Laboratory of Cardiovascular Sciences,
National Institutes of Health,
Baltimore, Md
To the Editor:
I have recently completed reading "Paclitaxel Inhibits
Arterial Smooth Muscle Cell Proliferation and Migration In
Vitro and In Vivo Using Local Drug Delivery," published in the July
15, 1997, issue of Circulation. My questions concerning this study
are related to the claimed statistical significance of the in vivo
data. According to the published methodology, the data were
analyzed by a two-tailed unpaired t test. Having
applied this test to verify the significance between the reported
means, I find that none of the presented in vivo data have any
statistical significance, and I am curious whether Axel et al, in
error, might have used a paired t test.
Department of Cardiology,
University of Tübingen,
Tübingen, Germany
We thank Dr Heller for his comments on our article. After
reviewing of the original data, we must admit that some statistical
data of the in vivo part of the study were reported incorrectly. This
was due to a misunderstanding between the statistician and the authors
of the manuscript with regard to the probability values. Unfortunately,
this error leads to statistical significance that does not exist in
reality. However, we want to emphasize that the in vitro data were not
affected by this error. The original data, the mean values, and the
correct probability values are reported as follows in the
Table
© 1998 American Heart Association, Inc.
Correspondence
Paclitaxel and Arterial Smooth Muscle Cell Proliferation
View this table:
[in a new window]
Table 1.
Response
. The
correct probability values are
P=.18 for mean intimal wall area, P=.45 for
intimal wall thickness, and P=.31 for degree of
stenosis. Therefore, paclitaxel applied with the microporous
balloon was not able to inhibit intimal growth in this preliminary in
vivo study. However, concerning the conclusion of our study, we have
completed comprehensive experiments with the double-balloon catheter
and paclitaxel in which we could show in vivo efficacy. The results
have been submitted for publication. We sincerely apologize for
the errors.
This article has been cited by other articles:
![]() |
S. Yasuda, T. Noguchi, M. Gohda, T. Arai, N. Tsutsui, Y. Nakayama, T. Matsuda, and H. Nonogi Local delivery of low-dose docetaxel, a novel microtubule polymerizing agent, reduces neointimal hyperplasia in a balloon-injured rabbit iliac artery model Cardiovasc Res, February 1, 2002; 53(2): 481 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Creel, M. A. Lovich, and E. R. Edelman Arterial Paclitaxel Distribution and Deposition Circ. Res., April 28, 2000; 86(8): 879 - 884. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |